Valcke Mathieu, Krishnan Kannan
Département de santé environnementale et santé au travail, Université de Montréal, CP 6128, Succursale Centre-Ville, Montréal, Québec, Canada, H3C 3 J7; Institut national de santé publique du Québec, 190 Boul. Crémazie Est, Montréal, QC, Canada, H2P 1E2.
J Appl Toxicol. 2014 Mar;34(3):227-40. doi: 10.1002/jat.2919. Epub 2013 Sep 13.
A default uncertainty factor of 3.16 (√10) is applied to account for interindividual variability in toxicokinetics when performing non-cancer risk assessments. Using relevant human data for specific chemicals, as WHO/IPCS suggests, it is possible to evaluate, and replace when appropriate, this default factor by quantifying chemical-specific adjustment factors for interindividual variability in toxicokinetics (also referred to as the human kinetic adjustment factor, HKAF). The HKAF has been determined based on the distributions of pharmacokinetic parameters (e.g., half-life, area under the curve, maximum blood concentration) in relevant populations. This article focuses on the current state of knowledge of the use of physiologically based algorithms and models in characterizing the HKAF for environmental contaminants. The recent modeling efforts on the computation of HKAF as a function of the characteristics of the population, chemical and its mode of action (dose metrics), as well as exposure scenario of relevance to the assessment are reviewed here. The results of these studies, taken together, suggest the HKAF varies as a function of the sensitive subpopulation and dose metrics of interest, exposure conditions considered (route, duration, and intensity), metabolic pathways involved and theoretical model underlying its computation. The HKAF seldom exceeded the default value of 3.16, except in very young children (i.e., <≈ 3 months) and when the parent compound is the toxic moiety. Overall, from a public health perspective, the current state of knowledge generally suggest that the default uncertainty factor is sufficient to account for human variability in non-cancer risk assessments of environmental contaminants.
在进行非癌症风险评估时,应用默认不确定性因子3.16(√10)来考虑毒代动力学中的个体间变异性。按照世界卫生组织/国际化学品安全规划署的建议,利用特定化学品的相关人体数据,通过量化毒代动力学中个体间变异性的化学物质特异性调整因子(也称为人体动力学调整因子,HKAF),有可能评估并在适当时替代该默认因子。HKAF是根据相关人群中药代动力学参数(如半衰期、曲线下面积、最大血药浓度)的分布确定的。本文重点关注基于生理学的算法和模型在表征环境污染物HKAF方面的应用现状。本文回顾了最近关于HKAF计算的建模工作,HKAF是人群特征、化学物质及其作用模式(剂量指标)以及与评估相关的暴露情景的函数。综合这些研究结果表明,HKAF随敏感亚群和感兴趣的剂量指标、所考虑的暴露条件(途径、持续时间和强度)、涉及的代谢途径以及其计算所依据的理论模型而变化。HKAF很少超过默认值3.16,除非是在非常年幼的儿童(即<≈3个月)以及母体化合物为毒性部分的情况下。总体而言,从公共卫生角度来看,目前的知识状况普遍表明,默认不确定性因子足以在环境污染物的非癌症风险评估中考虑人类变异性。